Professor of Surgery, University Tex Houston
Thoracic Surgery
Dr. Garrett L. Walsh, MD
|
|
Give Review
Dr. Garrett L. Walsh practices Thoracic Surgery. He has 6 awards "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer", "Fellow (FCCM)", "Super Doctor" and "Fellow (FACS)". Garrett L. Walsh, MD is a published doctor as well. He has 67 publications published. The latest was: Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
Publications
- Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
- Microsurgical reconstruction of combined tracheal and total Esophageal defects.
- Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small-Cell Lung Cancer.
- Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung Cancer.
- Limitations of 18F-2-Deoxy-d-Glucose Positron Emission Tomography in N1 Detection in Patients With Pathologic Stage II-N1 and Implications for Management.
- Surgical therapy of ground-glass opacities.
- Pulmonary adenocarcinoma T1N0M0 and its classification.
- Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lun...
- Serious postoperative infections following resection of common solid Tumors: outcomes, costs, and impact of hospital surgical volume.
- The Influence of Histopathologic Tumor Viability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal Adenocarcinoma.
- Visceral pleural invasion is not predictive of survival in patients with lung Cancer and smaller tumor size.
- Diaphragmatic Hernia After Esophagectomy in 440 Patients With Long-Term Follow-Up.
- Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer.
- Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal Adenocarcinoma.
- Fibrosingmediastinitis and consequent superior vena cava syndrome - A case report.
- Does the Timing of Esophagectomy After Chemoradiation Affect Outcome?
- Improved survival after resection of liver and Lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited Lung metastatic dis...
- Technical challenges of total Esophageal reconstruction using a supercharged jejunal flap.
- Progression after chemotherapy is a novel predictor of poor outcomes after Pulmonary metastasectomy in sarcoma patients.
- The prognostic factors of chest wall metastasis resection.
- Long-term outcomes of microsurgical reconstruction for large tracheal defects.
- The influence of high body mass index on the prognosis of patients with Esophageal cancer after surgery as primary therapy.
- Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experience.
- Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroEsophageal junction.
- Association of age and survival in patients with gastroEsophageal cancer undergoing surgery with or without preoperative therapy.
- Impact of tumor length on long-term survival of pT1 Esophageal adenocarcinoma.
- Application of the revised lung Cancer staging system (IASLC Staging Project) to a Cancer center population.
- Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung Cancer.
- Superior sulcus Tumors with vertebral body involvement: a multimodality approach.
- Management of primary pulmonary Artery sarcomas.
- Esophageal tumor length is independently associated with long-term survival.
- The surgical instrument counting process: a statistician's plea for terminology clarification.
- 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).
- Imaging of non-small cell lung Cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response.
- Imaging of non-small cell lung Cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management.
- Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung Cancer.
- Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or...
- The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with Esophageal adenocarcinoma.
- Primary tracheal malignant neoplasms: the University of Texas MD Anderson Cancer Center experience.
- Histologic subtypes as determinants of outcome in Esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy.
- Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in Esophageal adenocarcinoma.
- Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response.
- The evolution of treatment outcomes for resected stage IIIA non-small cell lung Cancer over 16 years at a single institution.
- Long-segment, supercharged, pedicled jejunal flap for total Esophageal reconstruction.
- Intrathoracic leaks following esophagectomy are no longer associated with increased mortality.
- Integrated computed tomography-positron emission tomography in patients with potentially resectable Malignant pleural mesothelioma: Staging implications.
- Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with Malignant pleural mesotheli...
- Proposed revision of the Esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).
- Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus.
- Anterior stabilization of the upper thoracic spine via an "interaortocaval subinnominate window": case report and description of operative technique.
- Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III Esophageal cancer patients.
- Transdiaphragmatic radiofrequency ablation of liver Tumors.
- 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with es...
- Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical Esophageal resection.
- Vertebral body resection.
- Cost-effectiveness of Pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Tex...
- Risk factors associated with Atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients.
- Is there a role for surgery in the management of metastatic urothelial Cancer? The M. D. Anderson experience.
- Postoperative pulmonary complications after preoperative chemoradiation for Esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.
- Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced Esophageal cancer.
- Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain Lung canc...
- Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized pla...
- Induction of p53-regulated genes and tumor regression in lung Cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.
- Treatment outcomes of resected Esophageal cancer.
- Incidence of major Pulmonary morbidity after pneumonectomy: association with timing of smoking cessation.
- Salvage esophagectomy for recurrent Tumors after definitive chemotherapy and radiotherapy.
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- Chest CT (incl. Heart and Lungs)
- Esophagectomy (Esophagogastrostomy, Esophagojejunostomy)
- View All
Conditions Treated
- Aortic Aneurysm
- Aortic Ectasia
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiac Surgery
- Critical Care Surgery
- Thoracic Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Fellow (FCCM)
- Super Doctor
- Fellow (FACS)
Education
-
Queen's University at Kingston
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1164528071 | |
| NPPES Provider LastName | WALSH | |
| NPPES Provider FirstName | GARRETT | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Thoracic Surgery | |
| Total Claim Count | 87.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 20.69 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164528071 |
| Last Name Of The Provider | WALSH |
| First Name Of The Provider | GARRETT |
| View All |
Similar Doctors
|
|
Dr. Mohammed S. Ghanamah, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Reardon, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Karl E. Tomm, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James P. Bonar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey S. Heinle, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Matthew T. Harting, MD |
|
|
Dr. John B. Holcomb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth L. Mattox, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reza J. Mehran, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Adel D. Irani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ethan A. Taub, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip R. Adams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mario O. Kapusta, MD |
|
|
Dr. Shabir Bhimji, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Oscar H. Frazier, MD
This Doctor is OpenDoctor Recommended.
|